logo

For the Inventor, By the Inventor

Holbaek, Denmark

Pharmacosmos Holding A/s


USPTO Granted Patents = 25



Trademarks = 27

Forward Citations = 83

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Hans B Andreasen (15 out of 15 patents)

silverMedal Tobias Sidelmann Christensen (10 out of 10 patents)

bronzeMedal Lars Lykke Thomsen (9 out of 9 patents)

4.  Jay Copeland Strum (5 out of 53 patents)

5.  Philip Schaffalitzky De Muckadell (4 out of 4 patents)

6.  Claes Christian Strom (4 out of 4 patents)

7.  Hannah S White (3 out of 12 patents)

8.  Stephen E Schneider (3 out of 9 patents)

9.  Lars Christensen (3 out of 3 patents)

10.  Alexander Smith (2 out of 16 patents)

11.  Jaroslaw Mazurek (2 out of 4 patents)

12.  Jessica A Sorrentino (1 out of 7 patents)

13.  Andrew Beelen (1 out of 3 patents)

14.  Patrick Joseph Roberts (1 out of 24 patents)

15.  Christian Von Der Recke (1 out of 1 patent)


25 patents:

1. 12497404 - Morphic forms of trilaciclib and methods of manufacture thereof (2025-12-16),
2. 12479855 - Morphic forms of trilaciclib and methods of manufacture thereof (2025-11-25),
3. 12364697 - G1T38 superior dosage regimes (2025-07-22),
4. 12312360 - Substituted 1',2′-dihydro-3′H-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c][1,2,4]triazin]-3′-ones as cyclin-dependent kinase inhibitors (2025-05-27),
5. 12303486 - Treating iron deficiency with ferric carboxymaltose (2025-05-20),
6. 12295934 - Treating iron deficiency with ferric carboxymaltose (2025-05-13),
7. 12285431 - Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors (2025-04-29),
8. 12264135 - Synthesis of 1,4-diazaspiro[5.5]undecan-3-one (2025-04-01),
9. 12030962 - Stable iron oligosaccharide compound (2024-07-09),
10. 11851504 - Stable iron oligosaccharide compound (2023-12-26),
11. 11806329 - Treating iron deficiency with ferric carboxymaltose (2023-11-07),
12. 11633489 - Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant (2023-04-25),
13. 11484025 - Cryoprotecting agent, cryoprotecting and cryopreserved compositions, uses thereof, and methods of cryopreservation (2022-11-01),
14. 11471483 - Iron carbohydrate complex for treatment of restless leg syndrome (RLS) (2022-10-18),
15. 11111261 - Iron complex compounds for therapeutic use (2021-09-07),
Pharmacosmos Holding A/S is a global family-owned pharmaceutical company dedicated to researching, developing, manufacturing, and marketing medicines primarily used for the treatment of iron deficiency. With a history spanning more than 50 years, Pharmacosmos is committed to improving patient outcomes through innovative and high-quality pharmaceutical products. The company's portfolio includes a range of iron-based medicinal products that are recognized for their safety and therapeutic efficacy. Pharmacosmos proudly serves healthcare professionals and patients in over 80 countries around the world.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

25 Patents

#1 in Holbaek

#119 in Denmark

#24,950 in the World

...
Holbaek, Denmark

Pharmacosmos Holding A/s

Forward Citations = 83

22 inventors:

goldMedal Hans B Andreasen (15 out of 15 patents)

silverMedal Tobias Sidelmann Christensen (10 out of 10 patents)

bronzeMedal Lars Lykke Thomsen (9 out of 9 patents)

4.  Jay Copeland Strum (5 out of 53 patents)

5.  Philip Schaffalitzky De Muckadell (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…